Vecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized ...

FDA Drug Recall #D-1697-2012 — Class I — June 26, 2012

Recall Summary

Recall Number D-1697-2012
Classification Class I — Serious risk
Date Initiated June 26, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Ben Venue Laboratories Inc
Location Bedford, OH
Product Type Drugs
Quantity 797 boxes/10/20 mg vials

Product Description

Vecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized powder per carton, Rx Only, Mfr. By: Ben Venue Laboratories, Bedford, OH 44146: Mfg for: Bedford Labs, Bedford, OH 44146, NDC 55390-039-10.

Reason for Recall

Presence of Particulate Matter

Distribution Pattern

Nationwide

Lot / Code Information

Lot #2067134 Exp 5/31/2013, NDC 55390-039-10

Other Recalls from Ben Venue Laboratories Inc

Recall # Classification Product Date
D-1543-2014 Class II CYTARAbine for Injection USP, lyophiled in glas... Jul 31, 2014
D-1326-2014 Class I Acetylcysteine Solution, USP, 10%, 30 mL vial, ... Feb 14, 2014
D-036-2013 Class II Leucovorin Calcium Injection USP, single use vi... Jul 5, 2012
D-1377-2012 Class II Octreotide Acetate Injection, 50 mcg/mL (0.05 m... May 1, 2012
D-1376-2012 Class II Midazolam HCl Injection, 5 mg/mL, 1 mL single u... May 1, 2012

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.